Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Open in API
Filings indexed 2,042 across all filing types
Latest filing 2025-12-31 Regulatory Filings
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is very short (818 characters) and contains no substantive financial data or detailed report content. It appears to be a digitally signed statement or certification by an individual named Ashok Kumar Jain, with no mention of financial results, management changes, or other report types. Given the brevity and nature of the content, it fits the criteria of an officer certification or attestation rather than a full report or announcement. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2025-12-31 English
Update regarding dissolution of step down wholly owned subsidiary "Dabur Tunisie"
Regulatory Filings
2025-12-31 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-12-23 English
Dabur India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve Board Meeting Intimation for Considering ....
Regulatory Filings
2025-12-22 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about a scheduled Board Meeting to consider and approve unaudited financial results for the quarter and nine months ending December 31, 2025. It references the SEBI Listing Obligations and Disclosure Requirements Regulations, indicating a regulatory compliance announcement. The document does not contain the financial results themselves, only a notice of the upcoming board meeting to approve those results. The document length is short (1778 characters), and it is clearly an announcement rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about an upcoming event related to financial results, not the actual Interim/Quarterly Report (IR).
2025-12-22 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2025 ("SEBI Listing Regulations") - ESG Rating assigned by SES ESG Research Private Limited.
Regulatory Filings
2025-12-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.